Clinical trial
First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic
NCT05052476 is registered in ClinicalTrials.gov with Astel Medica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic
- Lead sponsor
- Astel Medica
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 8, 2022
- Completion date
- October 16, 2023
- Enrollment
- 68 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.